| Authors: |
Jessen F; Department of Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany; German Center for Neurodegenerative Diseases, Bonn, Germany; Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany., Dell'Agnello G; Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: dell_agnello_grazia@lilly.com., Zimmer JA; Eli Lilly and Company, Indianapolis, IN, USA., Sapin C; Eli Lilly and Company, Indianapolis, IN, USA., Dichter S; Eli Lilly and Company, Indianapolis, IN, USA., Doty E; Eli Lilly and Company, Indianapolis, IN, USA., Epelbaum S; Eli Lilly and Company, Indianapolis, IN, USA., Evans CD; Eli Lilly and Company, Indianapolis, IN, USA., Hauck PM; Eli Lilly and Company, Indianapolis, IN, USA., Khanna R; Eli Lilly and Company, Indianapolis, IN, USA., Brooks DA; Eli Lilly and Company, Indianapolis, IN, USA., Sims JR; Eli Lilly and Company, Indianapolis, IN, USA., Agosta F; Unit of Neurology and Neuroimaging of Neurodegenerative Diseases, IRCCS Ospedale San Raffaele, Milano, Italy; 'Vita-Salute San Raffaele' University, Milano, Italy. |